Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsKevin Fitzgerald, William Querbes, James Butler, Stephanie Williams, Abigail Liebow, Gregory Hinkle, Martin A. Maier, Stuart Milstein, Satyanarayana Kuchimanchi, Muthiah Manoharan
Life of this patent
Estimating the term…
Abstract
The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the apolipoprotein C3 (APOC3) gene, and methods of using such RNAi agents to inhibit expression of APOC3 and methods of treating subjects having an APOC3 associated disorder, e.g., hypertriglyceridemia.
Claims21
A double stranded RNAi agent for inhibiting expression of apolipoprotein C3 (APOC3) in a cell, wherein said double stranded RNAi agent comprises a sense strand and an antisense strand forming a double-stranded region, wherein said antisense strand comprises the nucleotide sequence of 5′-UUCUUGUCCAGCUUUAUUGGGAG-3′ (SEQ ID NO:234),
- wherein substantially all of the nucleotides of at least one strand are modified nucleotides, and
- wherein said sense strand is conjugated to a ligand attached at the 3′-terminus.
A double stranded RNAi agent capable of inhibiting the expression of apolipoprotein C3 (APOC3) in a cell, wherein said double stranded RNAi agent comprises a sense strand and an antisense strand forming a double stranded region, wherein said antisense strand comprises the nucleotide sequence of 5′-UUCUUGUCCAGCUUUAUUGGGAG-3′ (SEQ ID NO:234), wherein each strand is about 15 to about 30 nucleotides in length, wherein said double stranded RNAi agent is represented by formula (III):
- (III)
- sense:
- 5′ np-Na-(XXX)i-Nb-YYY-Nb-(ZZZ)j-Na-nq 3′
- antisense:
- 3′ np′-Na′-(X′X′X′)k-Nb′-Y′Y′Y′-Nb′-(Z′Z′Z′)1-
- Na′-nq′ 5′
- wherein:
- i, j, k, and 1 are each independently 0 or 1;
- p, p′, q, and q′ are each independently 0-6;
- each Na and Na′ independently represents an oligonucleotide sequence comprising 0-25 nucleotides which are either modified or unmodified or combinations thereof, each sequence comprising at least two differently modified nucleotides;
- each Nb and Nb′ independently represents an oligonucleotide sequence comprising 0-10 nucleotides which are either modified or unmodified or combinations thereof;
- each np, np′, nq, and nq′, each of which may or may not be present, independently represents an overhang nucleotide;
- XXX, YYY, ZZZ, X′X′X′, Y′Y′Y′, and Z′Z′Z′ each independently represent one motif of three identical modifications on three consecutive nucleotides;
- and
- wherein the sense strand is conjugated to at least one ligand.
Dependencies are inferred from the claim text.